Iteos Therapeutics Inc — Company Overview, News & Financial Data

Iteos Therapeutics (NASDAQ:ITOS) is a biotechnology firm focused on the discovery, development, and commercialization of novel cancer immunotherapies. Its aim is to revolutionize cancer treatment by developing therapies that harness the body's immune system to fight cancer more effectively. The company's pipeline includes innovative candidates targeting the adenosine pathway and other immune checkpoint pathways, designed to address a wide range of tumors. By prioritizing patient-centered research, Iteos Therapeutics seeks to advance the scientific understanding of cancer immunotherapy and bring new treatments to market that improve the lives of those facing this challenging disease.